Kelly P. Longo

1.6k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

Kelly P. Longo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Kelly P. Longo has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Kelly P. Longo's work include Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Kelly P. Longo is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Kelly P. Longo collaborates with scholars based in United States and Japan. Kelly P. Longo's co-authors include R. Michael Snider, Manoj C. Desai, John Lowe, Susan E. Drozda, Jay W. Constantine, Wesley Lebel, Heidi A. Woody, Fredric J. Vinick, Hans-Jürgen Hess and Robin W. Spencer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Kelly P. Longo

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor

1991 727 citations R. Michael Snider, Jay W. Constantine et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly P. Longo United States	11	1.0k	947	366	194	92	14	1.4k
Susan E. Drozda United States	15	829 0.8×	774 0.8×	273 0.7×	281 1.4×	63 0.7×	25	1.3k
Fredric J. Vinick United States	10	650 0.6×	687 0.7×	234 0.6×	191 1.0×	58 0.6×	25	1.0k
Atsushi Nagahisa United States	19	519 0.5×	517 0.5×	289 0.8×	145 0.7×	51 0.6×	29	1.1k
Robert W. McNutt United States	18	867 0.8×	892 0.9×	306 0.8×	199 1.0×	28 0.3×	29	1.3k
Colin F. C. Smith Netherlands	12	1.0k 1.0×	957 1.0×	299 0.8×	158 0.8×	19 0.2×	18	1.3k
David G. Witte United States	23	328 0.3×	829 0.9×	222 0.6×	133 0.7×	30 0.3×	56	1.4k
Paola Petrillo Italy	18	669 0.6×	643 0.7×	278 0.8×	68 0.4×	31 0.3×	36	986
Anna Rita Renzetti Italy	16	422 0.4×	458 0.5×	150 0.4×	83 0.4×	53 0.6×	45	739
Hans-Jürgen Hess United States	7	588 0.6×	522 0.6×	224 0.6×	101 0.5×	52 0.6×	10	808
Alain Boudon France	8	455 0.4×	524 0.6×	140 0.4×	126 0.6×	38 0.4×	10	859

Countries citing papers authored by Kelly P. Longo

Since Specialization

Citations

This map shows the geographic impact of Kelly P. Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly P. Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly P. Longo more than expected).

Fields of papers citing papers by Kelly P. Longo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly P. Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly P. Longo. The network helps show where Kelly P. Longo may publish in the future.

Co-authorship network of co-authors of Kelly P. Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly P. Longo. A scholar is included among the top collaborators of Kelly P. Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly P. Longo. Kelly P. Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lowe, John, Susan E. Drozda, Stafford McLean, et al.. (1994). Aza-Tricyclic Substance P Antagonists. Journal of Medicinal Chemistry. 37(18). 2831–2840. 20 indexed citations

Lowe, John, Frank E. Ewing, R. Michael Snider, et al.. (1994). 2-Aryl-1-azabicyclo[2.2.2]octanes as novel nonpeptide substance P antagonists. Bioorganic & Medicinal Chemistry Letters. 4(6). 839–842. 7 indexed citations

McLean, Stafford, R. Michael Snider, Manoj C. Desai, et al.. (1993). CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor. Regulatory Peptides. 46(1-2). 329–331. 29 indexed citations

Lowe, John, Susan E. Drozda, R. Michael Snider, et al.. (1993). Discovery of CP-96,345 and its characterization in disease models involving substance P. Regulatory Peptides. 46(1-2). 20–23. 11 indexed citations

McLean, Stafford, Alan H. Ganong, P A Seymour, et al.. (1993). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 472–479. 205 indexed citations

Lowe, John, Susan E. Drozda, R. Michael Snider, Kelly P. Longo, & James P. Rizzi. (1993). Nuclear variations of quinuclidine substance P antagonists: 2-diphenylmethyl-1-azabicyclo[3.2.2]nonan-3-amines. Bioorganic & Medicinal Chemistry Letters. 3(5). 921–924. 7 indexed citations

Desai, Manoj C., et al.. (1992). Discovery of a potent substance P antagonist: recognition of the key molecular determinant. Journal of Medicinal Chemistry. 35(26). 4911–4913. 199 indexed citations

Lowe, John, Susan E. Drozda, R. Michael Snider, et al.. (1992). The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonist. Journal of Medicinal Chemistry. 35(14). 2591–2600. 89 indexed citations

McLean, Stafford, Alan H. Ganong, P A Seymour, et al.. (1992). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NK1 receptor. Regulatory Peptides. 37. S120–S120. 40 indexed citations

10.

Snider, R. Michael, Dennis Pereira, Kelly P. Longo, et al.. (1992). UK-73,093: A non-peptide neurotensin receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 2(12). 1535–1540. 14 indexed citations

11.

Lowe, John, Susan E. Drozda, R. Michael Snider, Kelly P. Longo, & Jon Bordner. (1991). Preparation and radiolabelling of CP-96,345, the first non-peptide substance P antagonist. Bioorganic & Medicinal Chemistry Letters. 1(2). 129–132. 21 indexed citations

12.

Snider, R. Michael, Kelly P. Longo, Susan E. Drozda, John Lowe, & Susan E. Leeman. (1991). Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.. Proceedings of the National Academy of Sciences. 88(22). 10042–10044. 38 indexed citations

13.

Snider, R. Michael, Jay W. Constantine, John Lowe, et al.. (1991). A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor. Science. 251(4992). 435–437. 727 indexed citations breakdown →

14.

Lowe, John, Susan E. Drozda, R. Michael Snider, Kelly P. Longo, & Jon Bordner. (1991). ChemInform Abstract: Preparation and Radiolabelling of CP‐96,345, the First Non‐Peptide Substance P Antagonist.. ChemInform. 22(35). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact